ERYTECH Announces Opening of Operations at its New Princeton, NJ GMP Manufacturing Facility Post author:admERY Post published:June 24, 2019 Post category:Newsroom Inauguration event held last week to officially open 30,000 sq. ft GMP manufacturing facility constructed in Princeton, NJ to produce lead product candidate eryaspase in the United States. You Might Also Like ERYTECH makes its 2016 Reference Document available April 3, 2017 ERYTECH to report positive initial results on the use of GRASPA® in ALL patients allergic to E. Coli and Erwinia derived asparaginases at ASH November 7, 2014 ERYTECH reports financial highlights for Q2 2015 July 8, 2015
ERYTECH to report positive initial results on the use of GRASPA® in ALL patients allergic to E. Coli and Erwinia derived asparaginases at ASH November 7, 2014